Measuring both pro-inflammatory (e.g., IFNγ, TNFα, and IL-2) and anti-inflammatory cytokines (e.g., IL-4, IL-6, and IL-10) provides an indication of immune activity in the tumor. The gene discussed is IL2; the disease is neoplasm.